Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$71,214
-$13,389 QoQ
Shares Held
283
-27.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#4,048
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Key Capital Management, INC holds $613,204 across 10 Drug Manufacturers - General names. ABBV ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
913 | $330,615 | |
| 2 | JNJ |
Johnson & Johnson
|
377 | $95,746 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
283 | $71,214 | |
| 4 | PFE |
Pfizer Inc
|
2,832 | $68,194 | |
| 5 | GSK |
GSK plc
|
412 | $21,597 | |
| 6 | MRK |
Merck & Co., Inc.
|
65 | $8,352 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
131 | $7,548 | |
| 8 | LLY |
ELI LILLY & Co
|
6 | $7,196 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,214 | 283 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $84,603 | 389 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $70,374 | 308 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||